Related Experiment Video
Updated: Aug 29, 2025
06:49
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
11.7K
Ibrexafungerp: A new triterpenoid antifungal
Allana J Sucher1, Annie Thai1, Charlene Tran1
1Regis University School of Pharmacy, Denver, CO, USA.
Summary
Ibrexafungerp offers a new oral treatment option for fungal infections like vulvovaginal candidiasis. This antifungal shows promise for various Candida and Aspergillus infections, including resistant strains.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Fungal infections pose a significant global health challenge, with limited treatment options for resistant strains.
- Vulvovaginal candidiasis (VVC) is a common infection, often treated with azoles like fluconazole.
- Emerging antifungal resistance necessitates the development of novel therapeutic agents.
Purpose of the Study:
- To review the pharmacology, microbiology, pharmacokinetics, pharmacodynamics, efficacy, safety, and role of ibrexafungerp in treating fungal infections.
- To evaluate ibrexafungerp as a potential alternative for vulvovaginal candidiasis and other invasive fungal infections.
Main Methods:
- Comprehensive review of existing literature on ibrexafungerp.
- Analysis of preclinical and clinical trial data for efficacy and safety.
- Pharmacological and microbiological profiling of the novel antifungal agent.
Main Results:
- Ibrexafungerp is the first triterpenoid antifungal, inhibiting 1,3-β-d-glucan synthesis with limited cross-resistance to echinocandins.
- Demonstrates fungicidal activity against Candida species, including fluconazole-resistant strains, and activity against Aspergillus species.
- Proven safe and effective for VVC in clinical trials; approved for specific populations, with ongoing trials for other indications.
Conclusions:
- Ibrexafungerp presents a valuable oral alternative to fluconazole for VVC in nonpregnant females.
- It holds potential for treating recurrent, complicated VVC, and certain invasive fungal infections.
- Further clinical trials are essential to establish its role in broader fungal infection management.
Related Concept Videos
01:29Fungal Group Zygomycota
108
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
108
01:26Fungal Phylum Basidiomycota
200
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
200
01:29Drugs for Treatment of Ulcerative Colitis in IBD
229
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
229
01:28Fungal Phylum Ascomycota
126
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
126
01:28Fungal Phylum Microsporidia
97
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
97
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
257
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
257